跳至主要内容
临床试验/NCT05934552
NCT05934552尚未招募不适用

Assesment of Lactulose vs Lactobacillus Acidophilus Effect in CKD Patients

Assiut University0 个研究点目标入组 150 人开始时间: 2023年12月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
主要终点
Assessment for usage of laxatives and probiotics ,and its role in improving uremic parameters in CKD patients and compare between both.

研究概览

简要总结

Assessment for usage of laxatives and probiotics ,and its role in improving uremic parameters of CKD as GFR, UREA ,CREATININE, CLINICAL and UREMIC assessment (lower limb edema ,UOP,base of chest ,vomiting ,dyspnea,blood pressure measurement)

详细描述

with advanced CKD stages ,also have been linked to the high prevalence of constipation in CKD,Lactulose is a synthetic disaccharide.Lactulose is poorly absorbed from the gastrointestinal tract remains virtually unchanged and is then fermented by gut microbiota that increase osmotic effects and intraluminal gas formation . lactulose reduces the nitrogen products and urea, creatinine, uric acid, and b2- microglobulin levels. Lactulose also suppress tubulointerstitial fibrosis in a rat model of a kidney disease study . Lactulose modifies the gut microbiota, increasing the abundance of Bifidobacteria and Lactobacilli after 8 weeks of 30 ml lactulose syrup thrice daily, and ameliorates CKD progression by suppressing uremic toxin production .probiotics include vast array of products with living organisms whose purpose is to improve intestinal microbial balance and produce beneficial effect on ones health .probiotics is an alternative therapy for patients with CKD

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • CKD stages 3,4,5 with non-dialysis receiving a diagnosis of constipation
  • DM nephropathy

排除标准

  • IBS (ulcerative colitis -crohns)
  • HCV ,HBV ,
  • autoimmune patients,
  • malignancy pt
  • cirrhotic patients
  • haemodialysis patients
  • cardiovascular patients
  • abdominal surgery,
  • gut obstruction,
  • pregnancy,
  • patients with ESRD on dialysis,
  • history of lactulose allergy.

结局指标

主要结局

Assessment for usage of laxatives and probiotics ,and its role in improving uremic parameters in CKD patients and compare between both.

时间窗: 1 year

Assessment for usage of laxatives and probiotics ,and its role in improving uremic parameters in CKD patients and compare between both.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdelrahman abobakr mokhtar

principal investigator

Assiut University

相似试验